image
NewAmsterdam Pharma Company N.V. NAMS
Healthcare - Biotechnology - NASDAQ - NL
Watchlist
$ 24.9
-0.28 %
$ 2.3 B
Market Cap
-11.27
P/E
BALANCE SHEET
347 M ASSETS
-34.71%
Growth Rates
1Year -34.71%
3Years 235.02%
5Years 0.00%
7Years 0.00%
10Years 0.00%
58.7 M LIABILITIES
24.74%
Growth Rates
1Year 24.74%
3Years 66.11%
5Years 0.00%
7Years 0.00%
10Years 0.00%
288 M EQUITY
-40.48%
Growth Rates
1Year -40.48%
3Years 335.55%
5Years 0.00%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition NewAmsterdam Pharma Company N.V.
image
Current Assets 347 M
Cash & Short-Term Investments 340 M
Receivables 0
Other Current Assets 6.34 M
Non-Current Assets 278 K
Long-Term Investments 0
PP&E 91.8 K
Other Non-Current Assets 186 K
Current Liabilities 45.3 M
Accounts Payable 16.9 M
Short-Term Debt 60 K
Other Current Liabilities 28.4 M
Non-Current Liabilities 8 M
Long-Term Debt 0
Other Non-Current Liabilities 8 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020
ASSETS
Cash & Cash Equivalents 340.4 438.5 53.1 7.9
Short Term Investments 0 0 0 0
Receivables 0 2.1 4.9 0
Inventory 0 21.5 K 735 0
Other Current Assets 4.5 8.2 7.5 1.7
Total Current Assets 346.8 448.1 58.9 9.2
PP&E 91.8 K 0.1 0.2 12 K
Intangible Assets 0.2 82.9 0 0
Goodwill 0 0.2 0 0
Long Term Investments 0 0 0.7 112.8
Other Long Term Assets 16.3 K 0.1 353 (112.8)
Other Assets 27.9 K 0 0 0
Total Assets 347.1 531.6 59.8 9.2
LIABILITIES
Accounts Payable 16.9 11.9 7.0 0.5
Short Term Debt 60 K 66 K 60 K 11.7
Other Current Liabilities 19.4 9.7 1.3 0.7
Total Current Liabilities 45.3 35.5 9.9 12.8
Long Term Debt 0 60 K 0.1 0
Deferred Tax Income 0 0 0 0
Other Liabilities 7.1 6.7 14.7 K 0
Total Liabilities 58.7 47.1 10.0 12.8
EQUITY
Common Stock 10.2 599.2 83.9 2.5
Retained Earnings (317.0) (119.4) (34.7) (6.1)
Other Accumulative Comprehensive Income/Loss 4.4 4.7 0.6 0
Total Equity 288.4 484.5 49.8 (3.6)
Total Liabilities and Equity 347.1 531.6 59.8 9.2
SHARES OUTSTANDING
Common Shares Outstanding 82.2 19.0 17.8 17.8